Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Compare Safety and Efficacy of Upadacitinib to Dupilumab in Adult Participants With Moderate to Severe Atopic Dermatitis

ClinicalTrials.gov ID: NCT03738397

Public ClinicalTrials.gov record NCT03738397. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 16, 2026, 9:18 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3b Multicenter, Randomized, Double-Blind, Double-Dummy, Active Controlled Study Comparing the Safety and Efficacy of Upadacitinib to Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate upadacitinib compared to dupilumab (Dupixent®) in adults with moderate to severe atopic dermatitis (AD) who are candidates for systemic therapy.

Study identification

NCT ID
NCT03738397
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AbbVie
Industry
Enrollment
673 participants

Conditions and interventions

Interventions

Biological · Drug

Eligibility (public fields only)

Age range
18 Years to 76 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 21, 2019 (Actual)
Primary completion
Aug 27, 2020 (Actual)
Completion
Dec 9, 2020 (Actual)
Last update posted
Mar 15, 2024

2019 – 2020

United States locations

U.S. sites
52
U.S. states
24
U.S. cities
46
Facility City State ZIP Site status
Clinical Research Center AL /ID# 210277 Birmingham Alabama 35209-6802 —
University of Arkansas for Medical Sciences /ID# 211688 Little Rock Arkansas 72205 —
Tien Q Nguyen MD, Inc /ID# 208934 Fountain Valley California 92708-3701 —
UCSF Fresno /ID# 213253 Fresno California 93701-2302 —
Jonathan Corren, MD. INC /ID# 208987 Los Angeles California 90025-4749 —
California Allergy and Asthma Medical Group /ID# 213680 Los Angeles California 90025-7014 —
Dermatology Research Associates /ID# 209097 Los Angeles California 90045 —
Los Angelos Cataract Center /ID# 208524 Los Angeles California 90056 —
Dermatology Clinical Trials /ID# 214622 Newport Beach California 92660-7853 —
UC Davis Health /ID# 209285 Sacramento California 95816 —
Ucsd /Id# 208990 San Diego California 92103 —
Clinical Science Institute /ID# 211022 Santa Monica California 90404-2102 —
The Community Research of South Florida /ID# 211145 Hialeah Florida 33016-1897 —
Miami Dermatology and Laser Institute /ID# 212938 Miami Florida 33173-3570 —
Florida International Rsrch cr /ID# 211562 Miami Florida 33173 —
Progressive Medical Research /ID# 211994 Port Orange Florida 32127 —
GCP Research /ID# 216020 St. Petersburg Florida 33705 —
Clinical Research Trials of Florida, Inc. /ID# 210751 Tampa Florida 33607 —
Integrated Clinical Research LLC /ID# 208831 West Palm Beach Florida 33406-6063 —
Georgia Pollens Clinical Research Centers, Inc /ID# 211092 Albany Georgia 31707-1282 —
Meridian Clinical Research Dermatology /ID# 213251 Savannah Georgia 31406-2632 —
Northwestern University Feinberg School of Medicine /ID# 208680 Chicago Illinois 60611-2927 —
Medical Dermatology Associates of Chicago /ID# 210265 Chicago Illinois 60654-6903 —
Sneeze, Wheeze, & Itch Associates, LLC /ID# 212058 Normal Illinois 61761 —
Dawes Fretzin, LLC /ID# 209187 Indianapolis Indiana 46256 —
Beacon Clinical Research, LLC /ID# 209280 Quincy Massachusetts 02169 —
Clarkston Skin Research /ID# 208739 Clarkston Michigan 48346 —
Henry Ford Health System /ID# 208741 Detroit Michigan 48202 —
Clinical Research Institute, Inc /ID# 210852 Minneapolis Minnesota 55402-2606 —
Allergy, Asthma & Immunology Associates, PC /ID# 213481 Lincoln Nebraska 68505-2343 —
Skin Specialists, PC /ID# 208843 Omaha Nebraska 68144 —
Dartmouth-Hitchcock Medical Center /ID# 213727 Lebanon New Hampshire 03756 —
Forest Hills Dermatology Group /ID# 209249 Kew Gardens New York 11415 —
Montefiore Medical Center /ID# 209647 The Bronx New York 10467 —
Wake Forest Univ HS /ID# 208892 Winston-Salem North Carolina 27157 —
Univ Hosp Cleveland /ID# 208852 Cleveland Ohio 44106 —
The Ohio State University /ID# 209254 Columbus Ohio 43210-1257 —
Southside Dermatology /ID# 212004 Tulsa Oklahoma 74132 —
Oregon Medical Res Center PC /ID# 208807 Portland Oregon 97223 —
Oregon Health and Science University /ID# 208809 Portland Oregon 97239 —
Medical University of South Carolina /ID# 211054 Charleston South Carolina 29425 —
Clinical Research Solutions, LLC /ID# 212542 Jackson Tennessee 38305-2163 —
Orion Clinical Research /ID# 208765 Austin Texas 78759-4100 —
DiscoveResearch, Inc. /ID# 213171 Bryan Texas 77802 —
Epiphany Dermatology - Fort Worth /ID# 211187 Fort Worth Texas 76244-6548 —
Sante Clinical Research /ID# 212970 Kerrville Texas 78028-9640 —
Stephen Miller, MD PA /ID# 210071 San Antonio Texas 78249 —
Sugar Land Allergy, Asthma, and Immunology Center /ID# 211153 Sugar Land Texas 77479-3153 —
University of Utah /ID# 209001 Salt Lake City Utah 84112-5500 —
Clinical Research Partners, LLC /ID# 212262 Richmond Virginia 23220-4459 —
Premier Clinical Research /ID# 212142 Spokane Washington 99202 —
West Virginia Research Inst /ID# 212730 South Charleston West Virginia 25309 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 107 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03738397, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 15, 2024 · Synced Oct 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03738397 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →